speb/financial-data huggingface dataset:
Financial ratios for ALDNX.PA — annual report dated 2021-12-31
Total revenue: 23715172.727272727
Gross profit: 6270757.954545454
Operating income: 4497582.954545454
Net income: 5205453.409090909
Capital expenditures: 42045.454545454544
Operating cash flow: 7662500
Depreciation & amortization: 317045.45454545453
Net tangible assets: 8092000
Owner earnings: 5480453.409090909
Return on net tangible assets (%): 67.72680930661035
Capex to operating income (%): 0.9348455597236193
Buffett classification: The Great
Stock price: 7.9318181818181825
P/E ratio: 3.016066764771823
Shares outstanding: 1979369
Book value: 13282990.90909091
P/B ratio: 1.1819623404230566
Market cap (USD): 15699995.022727273
Debt to equity: 0.02802473292912535
Current ratio: 1.6687602223772664
Quick ratio: 1.6598902648489513
Effective tax rate (%): -2.3941065258374845
Interest coverage ratio: 392.99702114983614
COGS to revenue (%): 73.55803380957876
Free cash flow (dilution-adjusted): 7620454.545454546
Buyback yield (%): 0
Retained earnings: 5205453.409090909
Inventory turnover: 238.2118306099964
Receivables turnover: 10.290450195287942
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.861323422257136
FCF margin (%): 32.133244961319356
Rule of 40 score: 32.133244961319356
Financial ratios for ALDNX.PA — annual report dated 2022-12-31
Total revenue: 21435058.5106383
Gross profit: 6957858.5106382985
Operating income: 5188393.617021277
Net income: 4292578.723404256
Capital expenditures: 211702.12765957447
Operating cash flow: 5623404.255319149
Depreciation & amortization: 318198.9361702128
Net tangible assets: 1815843.6170212766
Owner earnings: 4399075.5319148945
Return on net tangible assets (%): 242.26070409803077
Capex to operating income (%): 4.080301983354828
Buffett classification: The Great
Stock price: 8.26595744680851
P/E ratio: 3.811550347655924
Shares outstanding: 1979369
Book value: 15598265.957446812
P/B ratio: 1.0489230001698222
Market cap (USD): 16361379.925531914
Debt to equity: 0.17847558068716035
Current ratio: 1.3680712739469538
Quick ratio: 1.3615678069671733
Effective tax rate (%): 11.730421278551537
Interest coverage ratio: 397.9998367879876
COGS to revenue (%): 67.53982030333582
Free cash flow (dilution-adjusted): 5315957.446808511
Buyback yield (%): 0
Retained earnings: 4292577.659574469
Inventory turnover: 244.7188045100613
Receivables turnover: 9.240338301056205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.718263514947406
FCF margin (%): 24.800293613241976
Revenue growth (%): -9.614579842432555
Rule of 40 score: 15.185713770809421
Financial ratios for ALDNX.PA — annual report dated 2023-12-31
Total revenue: 24474125.555555556
Gross profit: 10018751.11111111
Operating income: 8055983.333333333
Net income: 6287223.333333333
Capital expenditures: 118888.88888888889
Operating cash flow: 7878888.888888889
Depreciation & amortization: 339283.3333333333
Net tangible assets: -552752.2222222222
Owner earnings: 6507617.777777777
Return on net tangible assets (%): -1177.3119159277715
Capex to operating income (%): 1.4757836997621505
Buffett classification: The Great
Stock price: 19.622222222222224
P/E ratio: 6.177547117160534
Shares outstanding: 1979369
Book value: 13828918.888888886
P/B ratio: 2.8085795201954817
Market cap (USD): 38839618.37777778
Debt to equity: 0.13692385529936582
Current ratio: 1.0087039695467404
Quick ratio: 1.0055788369608825
Effective tax rate (%): 20.146898070571023
Interest coverage ratio: 8962.156983930778
COGS to revenue (%): 59.063905722111144
Free cash flow (dilution-adjusted): 7760000
Buyback yield (%): 0
Retained earnings: 6287223.333333333
Inventory turnover: 447.1502663687919
Receivables turnover: 11.277163178228296
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 52.94869500082049
FCF margin (%): 31.706955095842034
Revenue growth (%): 14.17802075701802
Rule of 40 score: 45.88497585286005
Financial ratios for ALDNX.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 727497.9166666667
Buffett classification: The Gruesome
Stock price: 16.666666666666668
Shares outstanding: 1979369
Book value: 13128529.166666666
P/B ratio: 2.5128087780841155
Market cap (USD): 32989483.333333336
Debt to equity: 0.02163711852717698
Current ratio: 1.1128032873554252
Quick ratio: 1.0973705706720749
Buyback yield (%): 0
Retained earnings: 4785792.708333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALDNX.PA — annual report dated 2024-12-31
Total revenue: 24000915.625
Gross profit: 9422308.333333334
Operating income: 7379331.25
Net income: 4785791.666666667
Capital expenditures: 97916.66666666667
Operating cash flow: 8200000
Depreciation & amortization: 251797.9166666667
Net tangible assets: 727497.9166666667
Owner earnings: 4939672.916666667
Return on net tangible assets (%): 678.9947852084341
Capex to operating income (%): 1.3269043406428824
Buffett classification: The Great
Stock price: 16.666666666666668
P/E ratio: 6.893213418190999
Shares outstanding: 1979369
Book value: 13128529.166666666
P/B ratio: 2.5128087780841155
Market cap (USD): 32989483.333333336
Debt to equity: 0.02163711852717698
Current ratio: 1.1128032873554252
Quick ratio: 1.0973705706720749
Effective tax rate (%): 19.322081145267138
COGS to revenue (%): 60.74187968262843
Free cash flow (dilution-adjusted): 8097916.666666667
Buyback yield (%): 0
Retained earnings: 4785792.708333334
Inventory turnover: 98.24686912082667
Receivables turnover: 13.39944345580795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 51.65624049104126
FCF margin (%): 33.740032227069115
Revenue growth (%): -1.933511084926745
Rule of 40 score: 31.80652114214237
Financial ratios for ALHAF.PA — annual report dated 2022-03-31
Total revenue: 1552222.2222222222
Gross profit: 895555.5555555555
Operating income: -5268888.888888889
Net income: -5341111.111111111
Capital expenditures: 961111.1111111111
Operating cash flow: -64444.444444444445
Depreciation & amortization: 265555.55555555556
Net tangible assets: 57082222.222222224
Owner earnings: -6036666.666666666
Return on net tangible assets (%): -10.575388328726591
Buffett classification: The Gruesome
Stock price: 8.833333333333334
Shares outstanding: 171299989
Book value: 60281111.111111104
P/B ratio: 25.101559592096294
Market cap (USD): 1513149902.8333335
Debt to equity: 0.1133946509870422
Current ratio: 11.421699625868518
Quick ratio: 11.421699625868518
Interest coverage ratio: -60.794871794871796
COGS to revenue (%): 42.30493915533285
SG&A to revenue (%): 27.344309234073013
Free cash flow (dilution-adjusted): -1025555.5555555555
Buyback yield (%): 0
Retained earnings: -9913333.333333334
Receivables turnover: 2.1360856269113153
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.632260868165651
FCF margin (%): -66.07015032211882
Rule of 40 score: -66.07015032211882
Financial ratios for ALHAF.PA — annual report dated 2023-03-31
Total revenue: 357608.6956521739
Gross profit: -526086.9565217391
Operating income: -13846739.130434781
Net income: -17892391.304347824
Capital expenditures: 6489130.434782608
Operating cash flow: -18322826.08695652
Depreciation & amortization: 565217.3913043478
Net tangible assets: 31452173.913043477
Owner earnings: -23816304.347826086
Return on net tangible assets (%): -75.72228366049212
Buffett classification: The Gruesome
Stock price: 2.0652173913043477
Shares outstanding: 171299989
Book value: 40094565.217391305
P/B ratio: 8.823433163445115
Market cap (USD): 353771716.41304344
Debt to equity: 0.13953425325995605
Current ratio: 3.0266725518632955
Quick ratio: 3.010908632322341
Interest coverage ratio: -179.4225352112676
COGS to revenue (%): 247.11246200607903
SG&A to revenue (%): 28.87537993920973
Free cash flow (dilution-adjusted): -25652173.913043477
Buyback yield (%): 0.5177128792828808
Retained earnings: -29414130.434782606
Inventory turnover: 3.252
Receivables turnover: 3.7816091954022992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.034398752679788
FCF margin (%): -7173.252279635259
Revenue growth (%): -76.96150135383274
Rule of 40 score: -7250.213780989091
Financial ratios for ALHAF.PA — annual report dated 2024-03-31
Total revenue: -94623.6559139785
Gross profit: -2300000
Operating income: -9858064.516129032
Net income: -10682795.698924731
Capital expenditures: 3674193.5483870967
Operating cash flow: -21916129.032258064
Depreciation & amortization: 2781720.430107527
Net tangible assets: 19815053.76344086
Owner earnings: -11575268.817204302
Return on net tangible assets (%): -58.41654004775343
Buffett classification: The Gruesome
Stock price: 0.5
Shares outstanding: 171299989
Book value: 28782795.698924728
P/B ratio: 2.975735762290795
Market cap (USD): 85649994.5
Debt to equity: 0.17909444112372983
Current ratio: 2.706591952681143
Quick ratio: 1.9170363452408752
Interest coverage ratio: -109.14285714285714
Free cash flow (dilution-adjusted): -25450537.6344086
Buyback yield (%): 0.06653736248847973
Retained earnings: -10675268.8172043
Inventory turnover: 0.20216855593888614
Receivables turnover: -0.048245614035087724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.892543125741582
Revenue growth (%): -126.46011046834657
Rule of 40 score: -126.46011046834657
Financial ratios for ALHAF.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 14145555.555555556
Buffett classification: The Gruesome
Stock price: 1.3444444444444443
Shares outstanding: 171299989
Book value: 23516666.666666664
P/B ratio: 9.793195685802033
Market cap (USD): 230303318.5444444
Debt to equity: 0.17713205764233406
Current ratio: 2.51741983180852
Quick ratio: 1.2795490250438961
Buyback yield (%): 0
Retained earnings: -6017777.777777778
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALHAF.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 6733695.652173913
Buffett classification: The Gruesome
Stock price: 0.5326086956521738
Shares outstanding: 171299989
Book value: 15543478.260869563
P/B ratio: 5.869719902797203
Market cap (USD): 91235863.70652172
Debt to equity: 0.37839160839160846
Current ratio: 1.654339177839988
Quick ratio: 0.6648003536172092
Buyback yield (%): 0
Retained earnings: -13364130.434782607
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALHAF.PA — annual report dated 2025-03-31
Total revenue: 496739.1304347826
Gross profit: -1017391.304347826
Operating income: -11992391.304347826
Net income: -13381521.739130434
Capital expenditures: 1038043.4782608695
Operating cash flow: -8707608.695652174
Depreciation & amortization: 1931521.7391304348
Net tangible assets: 6733695.652173913
Owner earnings: -12488043.478260867
Return on net tangible assets (%): -185.45601291364
Buffett classification: The Gruesome
Stock price: 0.5326086956521738
Shares outstanding: 171299989
Book value: 15543478.260869563
P/B ratio: 5.869719902797203
Market cap (USD): 91235863.70652172
Debt to equity: 0.37839160839160846
Current ratio: 1.654339177839988
Quick ratio: 0.6648003536172092
Interest coverage ratio: -128.2906976744186
COGS to revenue (%): 304.8140043763676
SG&A to revenue (%): 7.87746170678337
Free cash flow (dilution-adjusted): -9529347.826086955
Buyback yield (%): 0
Retained earnings: -13364130.434782607
Inventory turnover: 0.10370756402620607
Receivables turnover: 0.25096101043382757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.80329823167097
FCF margin (%): -1918.3807439824943
Rule of 40 score: -1918.3807439824943
Financial ratios for AMN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 122.33
Shares outstanding: 38786052
Market cap (USD): 4744697741.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMN — annual report dated 2022-12-31
Total revenue: 5243242000
Gross profit: 1716684000
Operating income: 647101000
Net income: 444050000
Capital expenditures: 75831000
Operating cash flow: 653733000
Depreciation & amortization: 137111000
Net tangible assets: -368562000
Owner earnings: 505330000
Return on net tangible assets (%): -137.10854618761564
Capex to operating income (%): 11.718572525772638
Buffett classification: The Great
Stock price: 102.82
P/E ratio: 8.980929775115413
Shares outstanding: 38786052
Book value: 1043634000
P/B ratio: 3.821245634619033
Market cap (USD): 3987981866.64
Debt to equity: 0.8249587499065765
Current ratio: 1.2747440650959923
Quick ratio: 1.2747440650959923
Effective tax rate (%): 26.80932845230698
Interest coverage ratio: 16.018144462597157
COGS to revenue (%): 67.25911182432547
SG&A to revenue (%): 17.862536194209614
Free cash flow (dilution-adjusted): 542745000
Buyback yield (%): 14.462628449360135
Retained earnings: 1240996000
Receivables turnover: 5.500379228555753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.87033408884279
FCF margin (%): 10.35132461938625
Rule of 40 score: 10.35132461938625
Financial ratios for AMN — annual report dated 2023-12-31
Total revenue: 3789254000
Gross profit: 1249581000
Operating income: 346231000
Net income: 210679000
Capital expenditures: 103687000
Operating cash flow: 372165000
Depreciation & amortization: 160927000
Net tangible assets: -754427000
Owner earnings: 267919000
Return on net tangible assets (%): -35.512912448785634
Capex to operating income (%): 29.9473472912593
Buffett classification: The Good
Stock price: 74.88
P/E ratio: 13.785425095809265
Shares outstanding: 38786052
Book value: 831256000
P/B ratio: 3.493869005168083
Market cap (USD): 2904299573.7599998
Debt to equity: 1.624390079590403
Current ratio: 1.28281978476531
Quick ratio: 1.28281978476531
Effective tax rate (%): 25.892665562156818
Interest coverage ratio: 6.395105282600665
COGS to revenue (%): 67.02303408533712
SG&A to revenue (%): 19.95743753255918
Free cash flow (dilution-adjusted): 248758000
Buyback yield (%): 14.624662133256203
Retained earnings: 1451675000
Receivables turnover: 5.075748016518852
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.264079764649141
FCF margin (%): 6.564827799878288
Revenue growth (%): -27.730705544394098
Rule of 40 score: -21.16587774451581
Financial ratios for AMN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.39
Shares outstanding: 38786052
Market cap (USD): 1644140744.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMN — annual report dated 2024-12-31
Total revenue: 2983781000
Gross profit: 919376000
Operating income: 119784000
Net income: -146979000
Capital expenditures: 80891000
Operating cash flow: 320418000
Depreciation & amortization: 173779000
Net tangible assets: -572200000
Owner earnings: -54091000
Capex to operating income (%): 67.53072196620585
Buffett classification: The Good
Stock price: 23.92
Shares outstanding: 38786052
Book value: 706620000
P/B ratio: 1.3129579743567974
Market cap (USD): 927762363.84
Debt to equity: 1.5535889162491863
Current ratio: 1.0900171312879614
Quick ratio: 1.0900171312879614
Interest coverage ratio: 1.7136235533111115
COGS to revenue (%): 69.18755096302309
SG&A to revenue (%): 21.197567783962697
Free cash flow (dilution-adjusted): 216210000
Buyback yield (%): 0
Retained earnings: 1304696000
Receivables turnover: 5.738250051444187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.405760178657947
FCF margin (%): 7.246175238732333
Revenue growth (%): -21.2567698021827
Rule of 40 score: -14.010594563450367
Financial ratios for AMN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.92
Shares outstanding: 38786052
Market cap (USD): 927762363.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMN — quarterly report dated 2025-03-31
Total revenue: 689533000
Gross profit: 198120000
Operating income: 12507000
Net income: -1092000
Capital expenditures: 9975000
Operating cash flow: 92671000
Depreciation & amortization: 39857000
Net tangible assets: -544342000
Owner earnings: 28790000
Capex to operating income (%): 79.75533701127368
Buffett classification: The Gruesome
Stock price: 24.46
Shares outstanding: 38786052
Book value: 715051000
P/B ratio: 1.326768065382749
Market cap (USD): 948706831.9200001
Debt to equity: 1.4503343118183178
Current ratio: 1.077472009398041
Quick ratio: 1.077472009398041
Effective tax rate (%): 696.7213114754098
Interest coverage ratio: 1.0148490749756574
COGS to revenue (%): 71.26751003940348
SG&A to revenue (%): 21.42479040161965
Free cash flow (dilution-adjusted): 73315000
Buyback yield (%): 0
Retained earnings: 1303604000
Receivables turnover: 1.3978219752640937
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6898990222155539
FCF margin (%): 10.632558557748505
Rule of 40 score: 10.632558557748505
Financial ratios for AMN — quarterly report dated 2025-06-30
Total revenue: 658175000
Gross profit: 196399000
Operating income: 4062000
Net income: -116202000
Capital expenditures: 9800000
Operating cash flow: 78548000
Depreciation & amortization: 39885000
Net tangible assets: -470731000
Owner earnings: -86117000
Capex to operating income (%): 241.260462826194
Buffett classification: The Gruesome
Stock price: 20.67
Shares outstanding: 38786052
Book value: 607596000
P/B ratio: 1.3194749386763573
Market cap (USD): 801707694.84
Debt to equity: 1.5730287888662862
Current ratio: 0.9960044836248328
Quick ratio: 0.9960044836248328
Interest coverage ratio: 0.35757042253521126
COGS to revenue (%): 70.16006381281574
SG&A to revenue (%): 23.48676263911574
Free cash flow (dilution-adjusted): 59921000
Buyback yield (%): 0
Retained earnings: 1187402000
Receivables turnover: 1.4387533827946366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2478978724235282
FCF margin (%): 9.104113647586129
Revenue growth (%): -4.547715627823469
Rule of 40 score: 4.55639801976266
Financial ratios for AMN — quarterly report dated 2025-09-30
Total revenue: 634496000
Gross profit: 184412000
Operating income: 8438000
Net income: 29288000
Capital expenditures: 7908000
Operating cash flow: 22666000
Depreciation & amortization: 39628000
Net tangible assets: -413477000
Owner earnings: 61008000
Return on net tangible assets (%): -14.754871492247453
Capex to operating income (%): 93.71889073240104
Buffett classification: The Gruesome
Stock price: 19.36
P/E ratio: 6.409604332149685
Shares outstanding: 38786052
Book value: 644409000
P/B ratio: 1.165250588865146
Market cap (USD): 750897966.72
Debt to equity: 1.3731915600185596
Current ratio: 1.0519420394642192
Quick ratio: 1.0519420394642192
Effective tax rate (%): 22.90805717143534
Interest coverage ratio: 0.8764931962189675
COGS to revenue (%): 70.93567177728465
SG&A to revenue (%): 21.843163707887836
Free cash flow (dilution-adjusted): 8045000
Buyback yield (%): 0
Retained earnings: 1216690000
Receivables turnover: 1.3825400111126849
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5284355040020943
FCF margin (%): 1.2679354952592294
Revenue growth (%): -3.597675390283739
Rule of 40 score: -2.3297398950245096
Financial ratios for AMN — annual report dated 2025-12-31
Total revenue: 2730429000
Gross profit: 774058000
Operating income: 33167000
Net income: -95702000
Capital expenditures: 35629000
Operating cash flow: 269457000
Depreciation & amortization: 156600000
Net tangible assets: -397230000
Owner earnings: 25269000
Capex to operating income (%): 107.42304097446255
Buffett classification: The Gruesome
Stock price: 15.76
Shares outstanding: 38786052
Book value: 642106000
P/B ratio: 0.9519739412495757
Market cap (USD): 611268179.52
Debt to equity: 1.2508869252117252
Current ratio: 0.9441876408812806
Quick ratio: 0.9441876408812806
Interest coverage ratio: 0.727490074795464
COGS to revenue (%): 71.65068199905582
SG&A to revenue (%): 21.71900459598107
Free cash flow (dilution-adjusted): 203145000
Buyback yield (%): 0
Retained earnings: 1208994000
Receivables turnover: 6.218140453238049
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.187085598153107
FCF margin (%): 7.440039642122172
Revenue growth (%): -8.490971689946413
Rule of 40 score: -1.050932047824241
Financial ratios for AMN — quarterly report dated 2025-12-31
Total revenue: 748225000
Gross profit: 195127000
Operating income: 8160000
Net income: -7696000
Capital expenditures: 7946000
Operating cash flow: 75572000
Depreciation & amortization: 37230000
Net tangible assets: -397230000
Owner earnings: 21588000
Capex to operating income (%): 97.37745098039215
Buffett classification: The Gruesome
Stock price: 15.76
Shares outstanding: 38786052
Book value: 642106000
P/B ratio: 0.9519739412495757
Market cap (USD): 611268179.52
Debt to equity: 1.2508869252117252
Current ratio: 0.9441876408812806
Quick ratio: 0.9441876408812806
Interest coverage ratio: 0.6644951140065146
COGS to revenue (%): 73.92134718834575
SG&A to revenue (%): 20.329847305289185
Free cash flow (dilution-adjusted): 61864000
Buyback yield (%): 0
Retained earnings: 1208994000
Receivables turnover: 1.7039696474891086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5380835915497137
FCF margin (%): 8.26810117277557
Revenue growth (%): 17.924305275368166
Rule of 40 score: 26.192406448143736
Financial ratios for ARMK — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.45
Shares outstanding: 262953564
Market cap (USD): 5903307511.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARMK — annual report dated 2022-09-30
Total revenue: 13687269000
Gross profit: 1071722000
Operating income: 415392000
Net income: 194484000
Capital expenditures: 295622000
Operating cash flow: 463913000
Depreciation & amortization: 397975000
Net tangible assets: -4798731000
Owner earnings: 296837000
Return on net tangible assets (%): -6.185739521552677
Capex to operating income (%): 71.1669940682536
Buffett classification: The Good
Stock price: 21.58
P/E ratio: 29.177402311346945
Shares outstanding: 262953564
Book value: 3038480000
P/B ratio: 1.8675580919143782
Market cap (USD): 5674537911.12
Debt to equity: 2.562264026750217
Current ratio: 1.001857642048446
Quick ratio: 0.8337489492940412
Effective tax rate (%): 17.861227601982463
Interest coverage ratio: 1.0793411578846168
COGS to revenue (%): 92.16993543416149
SG&A to revenue (%): 1.8875569699112364
Free cash flow (dilution-adjusted): 69666000
Buyback yield (%): 0
Retained earnings: 406784000
Inventory turnover: 22.83828156397881
Receivables turnover: 6.372226725209117
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.521300719278094
FCF margin (%): 0.5089839324411611
Rule of 40 score: 0.5089839324411611
Financial ratios for ARMK — annual report dated 2023-09-30
Total revenue: 16083212000
Gross profit: 1308548000
Operating income: 625028000
Net income: 674108000
Capital expenditures: 365476000
Operating cash flow: 511647000
Depreciation & amortization: 409857000
Net tangible assets: -2867473000
Owner earnings: 718489000
Return on net tangible assets (%): -25.056521892272393
Capex to operating income (%): 58.473540385390734
Buffett classification: The Good
Stock price: 24.28
P/E ratio: 9.471052908317363
Shares outstanding: 262953564
Book value: 3720942000
P/B ratio: 1.715832317171297
Market cap (USD): 6384512533.92
Debt to equity: 1.8648062775501473
Current ratio: 1.0377855361675334
Quick ratio: 0.957525168654188
Effective tax rate (%): 20.660344546106288
Interest coverage ratio: 1.3375705670617137
COGS to revenue (%): 91.86388887990782
SG&A to revenue (%): 1.7015444427394228
Free cash flow (dilution-adjusted): 51774000
Buyback yield (%): 0.37061560885482153
Retained earnings: 964158000
Inventory turnover: 36.59749273606849
Receivables turnover: 8.118815939585458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.278384741371578
FCF margin (%): 0.32191330935636486
Revenue growth (%): 17.504901817886388
Rule of 40 score: 17.826815127242753
Financial ratios for ARMK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.99
Shares outstanding: 262953564
Market cap (USD): 9989605896.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARMK — annual report dated 2024-09-30
Total revenue: 17400701000
Gross profit: 1425684000
Operating income: 706510000
Net income: 262522000
Capital expenditures: 403480000
Operating cash flow: 726514000
Depreciation & amortization: 435547000
Net tangible assets: -3587707000
Owner earnings: 294589000
Return on net tangible assets (%): -8.211066288300579
Capex to operating income (%): 57.1088873476667
Buffett classification: The Good
Stock price: 37.99
P/E ratio: 38.05245235203145
Shares outstanding: 262953564
Book value: 3046468000
P/B ratio: 3.27907790147804
Market cap (USD): 9989605896.36
Debt to equity: 1.827241251180055
Current ratio: 0.8083512686838102
Quick ratio: 0.716376497611652
Effective tax rate (%): 28.221945102983298
Interest coverage ratio: 1.815325083763284
COGS to revenue (%): 91.80674387773227
SG&A to revenue (%): 1.6299745625190618
Free cash flow (dilution-adjusted): 236537000
Buyback yield (%): 0.1440997788035385
Retained earnings: 239709000
Inventory turnover: 41.21510780415943
Receivables turnover: 8.283062248513273
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.351023107007064
FCF margin (%): 1.3593532812270035
Revenue growth (%): 8.191703249326068
Rule of 40 score: 9.55105653055307
Financial ratios for ARMK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.69
Shares outstanding: 262953564
Market cap (USD): 9647766263.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARMK — quarterly report dated 2025-03-31
Total revenue: 4279298000
Gross profit: 359598000
Operating income: 174128000
Net income: 61973000
Capital expenditures: 114698000
Operating cash flow: 255948000
Depreciation & amortization: 117059000
Net tangible assets: -3689486000
Owner earnings: 64334000
Return on net tangible assets (%): -1.7437117256983763
Capex to operating income (%): 65.86993476063586
Buffett classification: The Good
Stock price: 34.04
P/E ratio: 36.10822180046149
Shares outstanding: 262953564
Book value: 3033766000
P/B ratio: 2.950438273274867
Market cap (USD): 8950939318.56
Debt to equity: 2.2555566250000822
Current ratio: 1.2061430346649042
Quick ratio: 1.0786563124703943
Effective tax rate (%): 26.633992731233203
Interest coverage ratio: 1.941139748506198
COGS to revenue (%): 91.59679928810753
SG&A to revenue (%): 1.5986500589582686
Free cash flow (dilution-adjusted): 124700000
Buyback yield (%): 0.9016595591554507
Retained earnings: 349500000
Inventory turnover: 9.65788274137315
Receivables turnover: 1.9176459991476726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6896031497444366
FCF margin (%): 2.91402935715157
Rule of 40 score: 2.91402935715157
Financial ratios for ARMK — quarterly report dated 2025-06-30
Total revenue: 4626451000
Gross profit: 370108000
Operating income: 182587000
Net income: 71952000
Capital expenditures: 110228000
Operating cash flow: 76677000
Depreciation & amortization: 121822000
Net tangible assets: -3668500000
Owner earnings: 83546000
Return on net tangible assets (%): -2.2773885784380536
Capex to operating income (%): 60.37012492674725
Buffett classification: The Good
Stock price: 41.4
P/E ratio: 81.2863733403024
Shares outstanding: 262953564
Book value: 3098228000
P/B ratio: 3.513710917853689
Market cap (USD): 10886277549.6
Debt to equity: 2.135174686950089
Current ratio: 1.288729315627446
Quick ratio: 1.14475034121659
Effective tax rate (%): 25.194934813798262
Interest coverage ratio: 2.113251004039305
COGS to revenue (%): 92.00017464791046
SG&A to revenue (%): 1.4200733996750425
Free cash flow (dilution-adjusted): -49126000
Buyback yield (%): 0.28359556202142194
Retained earnings: 393744000
Inventory turnover: 10.797036634924178
Receivables turnover: 1.9624602593876923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7313912681409576
FCF margin (%): -1.0618506496664506
Revenue growth (%): 8.112381984147868
Rule of 40 score: 7.050531334481418
Financial ratios for ARMK — quarterly report dated 2025-09-30
Total revenue: 5048464000
Gross profit: 416024000
Operating income: 217820000
Net income: 87242000
Capital expenditures: 123859000
Operating cash flow: 1175562000
Depreciation & amortization: 124260000
Net tangible assets: -3750068000
Owner earnings: 87643000
Return on net tangible assets (%): -2.3371042871755927
Capex to operating income (%): 56.86300615186851
Buffett classification: The Good
Stock price: 38.07
P/E ratio: 45.262820318944506
Shares outstanding: 262953564
Book value: 3162189000
P/B ratio: 3.1657317704539483
Market cap (USD): 10010642181.48
Debt to equity: 1.8095015826062262
Current ratio: 0.9932808379117394
Quick ratio: 0.8752095597004783
Effective tax rate (%): 19.47313525138685
Interest coverage ratio: 1.9367458899054835
COGS to revenue (%): 91.7593945405969
SG&A to revenue (%): 1.464683119459701
Free cash flow (dilution-adjusted): 1019439000
Buyback yield (%): 0.29639457151802184
Retained earnings: 453283000
Inventory turnover: 11.062120611510963
Receivables turnover: 2.256608398657066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2322409918438453
FCF margin (%): 20.19305277803308
Revenue growth (%): 9.121743643237549
Rule of 40 score: 29.31479642127063
Financial ratios for ARMK — annual report dated 2025-09-30
Total revenue: 18506299000
Gross profit: 1546630000
Operating income: 791846000
Net income: 326870000
Capital expenditures: 466573000
Operating cash flow: 921035000
Depreciation & amortization: 476345000
Net tangible assets: -3750068000
Owner earnings: 336642000
Return on net tangible assets (%): -8.97695721784245
Capex to operating income (%): 58.922189415618696
Buffett classification: The Good
Stock price: 38.07
P/E ratio: 30.62576003144981
Shares outstanding: 262953564
Book value: 3162189000
P/B ratio: 3.1657317704539483
Market cap (USD): 10010642181.48
Debt to equity: 1.8095015826062262
Current ratio: 0.9932808379117394
Quick ratio: 0.8752095597004783
Effective tax rate (%): 24.064248146151986
Interest coverage ratio: 2.1731563000856258
COGS to revenue (%): 91.64268339120642
SG&A to revenue (%): 1.5045633921725787
Free cash flow (dilution-adjusted): 373152000
Buyback yield (%): 1.696464591594186
Retained earnings: 453283000
Inventory turnover: 40.499154659165264
Receivables turnover: 8.272114003676933
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.114916446733915
FCF margin (%): 2.0163512974690403
Revenue growth (%): 6.3537555182403285
Rule of 40 score: 8.370106815709368
Financial ratios for ARMK — quarterly report dated 2025-12-31
Total revenue: 4831549000
Gross profit: 416176000
Operating income: 217549000
Net income: 96501000
Capital expenditures: 120033000
Operating cash flow: -782200000
Depreciation & amortization: 125954000
Net tangible assets: -3562205000
Owner earnings: 102422000
Return on net tangible assets (%): -2.8752415989534574
Capex to operating income (%): 55.17515594187976
Buffett classification: The Good
Stock price: 36.66
P/E ratio: 30.345762419381238
Shares outstanding: 262953564
Book value: 3233908000
P/B ratio: 2.9808756638222236
Market cap (USD): 9639877656.24
Debt to equity: 2.032335180840024
Current ratio: 1.272468577399821
Quick ratio: 1.1272746628715347
Effective tax rate (%): 28.849811988498118
Interest coverage ratio: 2.65565985912914
COGS to revenue (%): 91.38628212194475
SG&A to revenue (%): 1.5041345953440606
Free cash flow (dilution-adjusted): -920672000
Buyback yield (%): 0.4280344779406059
Retained earnings: 515843000
Inventory turnover: 10.649358198227748
Receivables turnover: 1.935665563330457
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.035579149023886
FCF margin (%): -19.055420942641792
Revenue growth (%): -4.296653397944405
Rule of 40 score: -23.352074340586196
Financial ratios for ATEC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.43
Shares outstanding: 153789305
Market cap (USD): 1757811756.1499999
Buyback yield (%): 1.7614514120565379
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEC — annual report dated 2022-12-31
Total revenue: 350867000
Gross profit: 233059000
Operating income: -121102000
Net income: -151293000
Capital expenditures: 49453000
Operating cash flow: -75134000
Depreciation & amortization: 43928000
Net tangible assets: -164815000
Owner earnings: -156818000
Buffett classification: The Gruesome
Stock price: 12.35
Shares outstanding: 153789305
Book value: -34667000
Market cap (USD): 1899297916.75
Debt to equity: -11.419015201776906
Current ratio: 1.840815150860517
Quick ratio: 1.1097645279758046
Interest coverage ratio: -21.998546775658493
COGS to revenue (%): 33.57625539021908
R&D to revenue (%): 12.549769570806033
SG&A to revenue (%): 85.50618895478914
Free cash flow (dilution-adjusted): -173970000
Buyback yield (%): 0.16011179568941103
Retained earnings: -932324000
Inventory turnover: 1.1604298618019917
Receivables turnover: 5.841941391941392
Capitalized R&D asset: 44033000
ROCI (R&D-adjusted, %): -21.530155437334216
FCF margin (%): -49.58289038296563
Rule of 40 score: -49.58289038296563
Financial ratios for ATEC — annual report dated 2023-12-31
Total revenue: 482262000
Gross profit: 310203000
Operating income: -148276000
Net income: -186638000
Capital expenditures: 80508000
Operating cash flow: -78485000
Depreciation & amortization: 59682000
Net tangible assets: -97338000
Owner earnings: -207464000
Buffett classification: The Gruesome
Stock price: 15.11
Shares outstanding: 153789305
Book value: 78116000
P/B ratio: 29.747508814455422
Market cap (USD): 2323756398.5499997
Debt to equity: 6.93429003021148
Current ratio: 2.862724815007552
Quick ratio: 1.9942947440567607
Interest coverage ratio: -8.910281834024397
COGS to revenue (%): 35.677494805728
R&D to revenue (%): 14.538777676864441
SG&A to revenue (%): 77.56779509892962
Free cash flow (dilution-adjusted): -246704000
Buyback yield (%): 0.04578793201662296
Retained earnings: -1118962000
Inventory turnover: 1.2573551979655369
Receivables turnover: 6.641538016608596
Capitalized R&D asset: 99617110
ROCI (R&D-adjusted, %): -15.551711035040597
Rosenberg metric: 1.7519587582040743
FCF margin (%): -51.155595920889475
Revenue growth (%): 37.448662883656766
Rule of 40 score: -13.706933037232709
Financial ratios for ATEC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.56
Shares outstanding: 153789305
Market cap (USD): 855068535.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEC — annual report dated 2024-12-31
Total revenue: 611562000
Gross profit: 424262000
Operating income: -122913000
Net income: -162123000
Capital expenditures: 83223000
Operating cash flow: -44651000
Depreciation & amortization: 83320000
Net tangible assets: -178663000
Owner earnings: -162026000
Buffett classification: The Gruesome
Stock price: 9.18
Shares outstanding: 153789305
Book value: -14169000
Market cap (USD): 1411785819.8999999
Debt to equity: -43.04721575269956
Current ratio: 2.7276345196241163
Quick ratio: 1.582312809587913
Interest coverage ratio: -4.940431689376583
COGS to revenue (%): 30.626494124880228
R&D to revenue (%): 13.198661787357619
SG&A to revenue (%): 73.6146130727547
Free cash flow (dilution-adjusted): -211064000
Buyback yield (%): 0
Retained earnings: -1281085000
Inventory turnover: 1.0686735439109
Receivables turnover: 7.369371106317857
Capitalized R&D asset: 142225940
ROCI (R&D-adjusted, %): -14.008228646281331
Rosenberg metric: 1.6267417813591956
FCF margin (%): -34.51228166563652
Revenue growth (%): 26.811152444107144
Rule of 40 score: -7.701129221529378
Financial ratios for ATEC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.18
Shares outstanding: 153789305
Market cap (USD): 1411785819.8999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEC — quarterly report dated 2025-03-31
Total revenue: 169180000
Gross profit: 115996000
Operating income: -31706000
Net income: -51907000
Capital expenditures: 9934000
Operating cash flow: -5039000
Depreciation & amortization: 21178000
Net tangible assets: -253313000
Owner earnings: -40663000
Buffett classification: The Gruesome
Stock price: 10.14
Shares outstanding: 153789305
Book value: -85939000
Market cap (USD): 1559423552.7
Debt to equity: -6.76380921351191
Current ratio: 2.7546952297099567
Quick ratio: 1.6723505602604625
Interest coverage ratio: -4.043616885601327
COGS to revenue (%): 31.436339992906966
R&D to revenue (%): 9.801394963943729
SG&A to revenue (%): 75.07802340702212
Free cash flow (dilution-adjusted): -38969000
Buyback yield (%): 0.19257115841302888
Retained earnings: -1332992000
Inventory turnover: 0.31124870517869996
Receivables turnover: 1.8906807031660353
Capitalized R&D asset: 16582000
ROCI (R&D-adjusted, %): -3.2058227850721273
FCF margin (%): -23.034046577609647
Rule of 40 score: -23.034046577609647
Financial ratios for ATEC — quarterly report dated 2025-06-30
Total revenue: 185544000
Gross profit: 129101000
Operating income: -11485000
Net income: -41144000
Capital expenditures: 10324000
Operating cash flow: 15548000
Depreciation & amortization: 20522000
Net tangible assets: -147040000
Owner earnings: -30946000
Buffett classification: The Gruesome
Stock price: 11.1
Shares outstanding: 153789305
Book value: 23771000
P/B ratio: 71.8127670480838
Market cap (USD): 1707061285.5
Debt to equity: 24.678347566362373
Current ratio: 2.87530483059202
Quick ratio: 1.7742826752451617
Interest coverage ratio: -0.9330571126817776
COGS to revenue (%): 30.420277669986636
R&D to revenue (%): 9.84995472771957
SG&A to revenue (%): 63.87002543870995
Free cash flow (dilution-adjusted): -12249000
Buyback yield (%): 0
Retained earnings: -1374136000
Inventory turnover: 0.332487040527804
Receivables turnover: 1.9343821349263441
Capitalized R&D asset: 29385940
ROCI (R&D-adjusted, %): -0.7255251757937233
Rosenberg metric: 0.7903147991798336
FCF margin (%): -6.601668606907256
Revenue growth (%): 9.672538125073887
Rule of 40 score: 3.0708695181666306
Financial ratios for ATEC — quarterly report dated 2025-09-30
Total revenue: 196503000
Gross profit: 137300000
Operating income: -9413000
Net income: -28578000
Capital expenditures: 9233000
Operating cash flow: 14040000
Depreciation & amortization: 20378000
Net tangible assets: -159736000
Owner earnings: -17433000
Buffett classification: The Gruesome
Stock price: 14.54
Shares outstanding: 153789305
Book value: 11506000
P/B ratio: 194.3417777420476
Market cap (USD): 2236096494.7
Debt to equity: 51.37780288545107
Current ratio: 1.991527227442545
Quick ratio: 1.2357704064304313
Interest coverage ratio: -0.7309364808200031
COGS to revenue (%): 30.12829320671949
R&D to revenue (%): 9.505707292000631
SG&A to revenue (%): 63.25755840877747
Free cash flow (dilution-adjusted): -13230000
Buyback yield (%): 0
Retained earnings: -1402714000
Inventory turnover: 0.35474264485589313
Receivables turnover: 2.0291930853590534
Capitalized R&D asset: 36395980
ROCI (R&D-adjusted, %): -1.423257553480925
Rosenberg metric: 0.4486211424819435
FCF margin (%): -6.7327216378375905
Revenue growth (%): 5.906415728883715
Rule of 40 score: -0.8263059089538753
Financial ratios for ATEC — quarterly report dated 2025-12-31
Total revenue: 212928000
Gross profit: 149491000
Operating income: -5362000
Net income: -21729000
Capital expenditures: 12964000
Operating cash flow: 20682000
Depreciation & amortization: 20485000
Net tangible assets: -156238000
Owner earnings: -14208000
Buffett classification: The Gruesome
Stock price: 21.04
Shares outstanding: 153789305
Book value: 12426000
P/B ratio: 260.39972454530823
Market cap (USD): 3235726977.2
Debt to equity: 47.97135039433446
Current ratio: 2.057150678681419
Quick ratio: 1.28405155697502
Interest coverage ratio: -0.4158523344191097
COGS to revenue (%): 29.79269987977157
R&D to revenue (%): 10.464100541027953
SG&A to revenue (%): 60.44249699428915
Free cash flow (dilution-adjusted): -13681000
Buyback yield (%): 0
Retained earnings: -1424443000
Inventory turnover: 0.3743832770708907
Receivables turnover: 2.1882759187700405
Capitalized R&D asset: 40827010
ROCI (R&D-adjusted, %): -0.4611711136664525
Rosenberg metric: 0.6526580652069168
FCF margin (%): -6.425176585512474
Revenue growth (%): 8.358651012961635
Rule of 40 score: 1.9334744274491618
Financial ratios for ATEC — annual report dated 2025-12-31
Total revenue: 764155000
Gross profit: 531888000
Operating income: -57966000
Net income: -143358000
Capital expenditures: 42455000
Operating cash flow: 45231000
Depreciation & amortization: 82563000
Net tangible assets: -156238000
Owner earnings: -103250000
Buffett classification: The Gruesome
Stock price: 21.04
Shares outstanding: 153789305
Book value: 12426000
P/B ratio: 260.39972454530823
Market cap (USD): 3235726977.2
Debt to equity: 47.97135039433446
Current ratio: 2.057150678681419
Quick ratio: 1.28405155697502
Interest coverage ratio: -1.2622708070206001
COGS to revenue (%): 30.395273210278017
R&D to revenue (%): 9.980697633333552
SG&A to revenue (%): 65.23885860852837
Free cash flow (dilution-adjusted): -78129000
Buyback yield (%): 0
Retained earnings: -1424443000
Inventory turnover: 1.370759661008947
Receivables turnover: 7.853274274438872
Capitalized R&D asset: 153487010
ROCI (R&D-adjusted, %): -7.911337046835322
Rosenberg metric: 1.333358110954186
FCF margin (%): -10.224234612087862
Revenue growth (%): 24.9513540736671
Rule of 40 score: 14.727119461579239
Financial ratios for BDMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.86
Shares outstanding: 31981751
Market cap (USD): 315340064.85999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDMD — annual report dated 2022-12-31
Total revenue: 5041835.344827586
Gross profit: 4028283.1896551726
Operating income: 2156201.724137931
Net income: 1835484.3390804597
Capital expenditures: 844345.2586206896
Operating cash flow: 69822.98850574713
Depreciation & amortization: 211211.35057471265
Net tangible assets: 3710162.7873563217
Owner earnings: 1202350.4310344828
Return on net tangible assets (%): 32.40694546158224
Capex to operating income (%): 39.158917700906045
Buffett classification: The Good
Stock price: 10.26
P/E ratio: 178.7717597331219
Shares outstanding: 31981751
Book value: 3703701.1494252877
P/B ratio: 88.595907720826
Market cap (USD): 328132765.26
Debt to equity: 0.28865665597010753
Current ratio: 2.107211239220188
Quick ratio: 2.0264986512109453
Effective tax rate (%): 12.029423487391567
Interest coverage ratio: 50.146069255419036
COGS to revenue (%): 20.10284124435392
R&D to revenue (%): 10.998184329769076
SG&A to revenue (%): 28.91251800239
Free cash flow (dilution-adjusted): -785655.316091954
Buyback yield (%): 0
Retained earnings: 569143.1034482758
Inventory turnover: 5.454729135688487
Receivables turnover: 1.4170604002898153
Capitalized R&D asset: 554510.3448275862
ROCI (R&D-adjusted, %): 57.72665226901006
FCF margin (%): -15.582724590519542
Rule of 40 score: -15.582724590519542
Financial ratios for BDMD — annual report dated 2023-12-31
Total revenue: 4424459.634317862
Gross profit: 3829887.3417721516
Operating income: 1779702.3909985935
Net income: 1499041.2095639943
Capital expenditures: 371095.358649789
Operating cash flow: -143454.8523206751
Depreciation & amortization: 142670.4641350211
Net tangible assets: 5016285.513361462
Owner earnings: 1270616.3150492264
Return on net tangible assets (%): 25.329824462040516
Capex to operating income (%): 20.851540152259215
Buffett classification: The Great
Stock price: 10.71
P/E ratio: 228.49575516981648
Shares outstanding: 31981751
Book value: 5022117.440225035
P/B ratio: 68.20321453786073
Market cap (USD): 342524553.21000004
Debt to equity: 0.3224408036966157
Current ratio: 2.1123470482941262
Quick ratio: 2.052133985446657
Effective tax rate (%): 13.763178237559352
Interest coverage ratio: 44.51275015742021
COGS to revenue (%): 13.438303017479738
R&D to revenue (%): 13.589250753737343
SG&A to revenue (%): 35.265790719459154
Free cash flow (dilution-adjusted): -514550.2109704641
Buyback yield (%): 0
Retained earnings: 2024496.0618846694
Inventory turnover: 3.6999157162499596
Receivables turnover: 0.998839002640241
Capitalized R&D asset: 972772.8452398273
ROCI (R&D-adjusted, %): 31.779673125169094
Rosenberg metric: -0.35778565672153184
FCF margin (%): -11.62967353073828
Revenue growth (%): -12.245058957410999
Rule of 40 score: -23.874732488149277
Financial ratios for BDMD — annual report dated 2024-12-31
Total revenue: 5073576.438356165
Gross profit: 4473115.7534246575
Operating income: 2097986.8493150687
Net income: 1725766.8493150685
Capital expenditures: 390914.79452054796
Operating cash flow: -864810.2739726028
Depreciation & amortization: 156045.34246575343
Net tangible assets: 5422580.684931507
Owner earnings: 1490897.3972602738
Return on net tangible assets (%): 27.49424091380035
Capex to operating income (%): 18.63285247227218
Buffett classification: The Great
Stock price: 7.6
P/E ratio: 140.8424942781045
Shares outstanding: 31981751
Book value: 5446640.821917809
P/B ratio: 44.62591082229947
Market cap (USD): 243061307.6
Debt to equity: 0.5250766099944774
Current ratio: 1.7738223259253778
Quick ratio: 1.7363740936239167
Effective tax rate (%): 10.57116174525572
Interest coverage ratio: 26.57250775992047
COGS to revenue (%): 11.835057424029975
R&D to revenue (%): 16.67075355883618
SG&A to revenue (%): 30.143665644736622
Free cash flow (dilution-adjusted): -1255725.0684931506
Buyback yield (%): 0
Retained earnings: 3666404.2465753425
Inventory turnover: 3.3807193865077045
Receivables turnover: 0.7951522326608177
Capitalized R&D asset: 1431629.9509682187
ROCI (R&D-adjusted, %): 30.896103357082303
Rosenberg metric: 1.069816937413961
FCF margin (%): -24.75029367843731
Revenue growth (%): 14.671097889638226
Rule of 40 score: -10.079195788799083
Financial ratios for BDMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5422580.684931507
Buffett classification: The Gruesome
Stock price: 7.6
Shares outstanding: 31981751
Book value: 5446640.821917809
P/B ratio: 44.62591082229947
Market cap (USD): 243061307.6
Debt to equity: 0.5250766099944774
Current ratio: 1.7738223259253778
Quick ratio: 1.7363740936239167
Buyback yield (%): 0
Retained earnings: 3666404.2465753425
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDMD — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 4953481.589958159
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 31981751
Book value: 4968489.679218968
P/B ratio: 23.559112772153412
Market cap (USD): 117053208.66000001
Debt to equity: 0.6333334559096291
Current ratio: 1.7127170713047994
Quick ratio: 1.6723881880290175
Buyback yield (%): 0
Retained earnings: 2154912.133891213
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRCK.L — annual report dated 2022-03-31
Total revenue: 684432894.7368422
Gross profit: 114214473.68421052
Operating income: 37503947.368421055
Net income: 16298684.210526315
Capital expenditures: 8065789.47368421
Operating cash flow: 25159210.52631579
Depreciation & amortization: 12751315.789473685
Net tangible assets: 4767105.263157895
Owner earnings: 20984210.52631579
Return on net tangible assets (%): 440.1876897598675
Capex to operating income (%): 21.50650808686805
Buffett classification: The Great
Stock price: 0.009868421052631578
P/E ratio: 0.19573181157665293
Shares outstanding: 323270660
Book value: 203268421.05263162
P/B ratio: 0.015694375792962376
Market cap (USD): 3190170.986842105
Debt to equity: 0.23868491235338285
Current ratio: 1.3020483333567643
Quick ratio: 1.104384867357411
Effective tax rate (%): 33.15766597848528
Interest coverage ratio: 12.673632725655848
COGS to revenue (%): 83.3125388095023
SG&A to revenue (%): 9.081471598653513
Free cash flow (dilution-adjusted): 14103947.368421052
Buyback yield (%): 0
Retained earnings: 47848684.21052632
Inventory turnover: 15.411308677098152
Receivables turnover: 4.249434273623671
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.562973541195605
FCF margin (%): 2.060676434005102
Rule of 40 score: 2.060676434005102